When knee cartilage damage needs more than rest

A familiar pattern is a knee that never quite settles after a twist in football or a run: swelling that returns after activity, a sharp “catch” on stairs, or occasional locking that makes the joint feel unreliable. NHS advice for knee pain and meniscus-type “cartilage damage” often starts with self-care, pain relief and physiotherapy, but persistent swelling or mechanical symptoms are among the reasons clinicians consider imaging and specialist assessment rather than more rest alone.

At that point, one key question is whether the problem looks like diffuse osteoarthritis (more general “wear and tear” across a compartment) or a focal cartilage defect (a more localised patch of damage, often after injury). The distinction matters because focal defects may be candidates for joint-preserving cartilage restoration, whereas widespread change with established arthritis more often pushes care towards symptom control and, later, arthroplasty pathways.

Surgeons usually describe cartilage damage by depth (often using Outerbridge or ICRS-style grading, from surface softening through to full-thickness loss) and by surface area. Practical treatment planning commonly groups defects into “smaller patches” versus “larger areas”, with a commonly cited split around 2–4 cm² when mapping options such as microfracture, osteochondral grafting or cell-based repair.

Most pathways still follow a stepwise “joint-preservation ladder”: symptom management (physio, load/weight management, activity adjustment and analgesia) → injection/biologic support in selected cases → cartilage restoration or scaffold-based repair for suitable focal lesions → knee replacement when preservation is no longer realistic. MRI is typically used to help define the cartilage lesion and to look for meniscal tears or ligament injuries that may need different operations, while arthroscopy can be used to confirm the lesion directly. In a 47-study meta-analysis, restorative options such as ACI/MACI, OAT and OCA were associated with clinically meaningful improvements in pain and function in appropriately selected tibiofemoral defects, which is one reason these procedures remain part of modern knee joint-preservation practice.

MACI knee surgery recovery and return to sport

MACI (matrix‑induced autologous chondrocyte implantation) is a two‑stage, cell‑based cartilage repair: a small cartilage sample is taken first, the cells are expanded, and then implanted on a collagen membrane to treat a focal knee defect. Published knee series describe it as a joint‑preserving option when overall joint health is still relatively well preserved, with durable improvements reported out to 10–17 years in a systematic review (with 9% reoperation and 7.4% progressing to total knee replacement in that review’s cohort). Rehabilitation is part of the procedure, and studies discussing arthroscopic versus open implantation also highlight that rehab planning is integral rather than an afterthought.

In uncomplicated cases, the first 0–2 weeks are dominated by swelling control and learning the “new normal” of moving around with crutches and a knee brace. Patient-facing MACI guidance sets an early target of pain‑free full knee extension by around 2–3 weeks, alongside simple home exercises. Even when pain is improving, a common early derailment is “too much too soon”: the knee becomes more swollen after a busy day on feet, stairs, or long car journeys, and rehab is temporarily dialled back until the effusion settles.

From about 2–12 weeks, the default pathway is a steady move towards full weightbearing and full range of motion, with brace and crutches gradually reduced as control and comfort allow. In sample timelines, many patients reach full weightbearing, full movement and brace weaning by roughly 8–12 weeks, and seated office work is sometimes possible from around 2 weeks if symptoms permit. Day‑to‑day reality varies sharply by job demands: a desk-based role may resume in short stints while still on crutches, whereas a trades role involving kneeling, lifting and ladders usually needs a longer, staged build-up.

Between 3 and 6 months, rehab tends to shift from “getting moving” to “getting strong”: gait retraining, progressive strengthening, balance work and low‑impact cardio (with patient materials specifically mentioning stationary cycling, plus a return to more demanding daily activities and, for many, driving). A broader return‑to‑play review places this period as the transition towards more advanced strengthening and the early building blocks of sport‑specific work.

After about 6–9+ months, sport is usually reintroduced in steps: first higher-load gym work and controlled running (often starting with a jog/walk progression), then change‑of‑direction drills, and only later a phased return to full training and competition. The main variables that shift timelines are the size and location of the defect, the level of swelling and pain during progression, and whether MACI is combined with other knee procedures (for example, realignment surgery), all of which can slow or reshape the plan.

Microfracture versus OATS and MACI in active knees

In an active knee, the practical difference between microfracture, OATS (mosaicplasty) and MACI is the type of “patch” created — and how well that patch tends to tolerate years of running, pivoting, kneeling or heavy work.

Microfracture is a keyhole technique where the surgeon makes small holes in the exposed bone at the base of the defect to stimulate healing. NHS patient information describes it as being used when cartilage damage is severe with bare bone exposed, and stresses that cartilage has limited natural healing and outcomes depend heavily on selection and rehabilitation. The tissue that fills in after microfracture is typically fibrocartilage, which some studies describe as mechanically less resilient than native (hyaline) joint cartilage under high loads.

OATS/mosaicplasty is closer to “borrowing a plug of good cartilage”. Small cylinders of bone-and-cartilage are moved from a low-load area of the knee into the defect, aiming to restore a more normal joint surface straight away. In a long-term comparative study of 203 knees, failure was more common after microfracture (66%) than after OATS (51%), and when failure happened it tended to happen sooner (about 4.0 years after microfracture versus 8.4 years after OATS). In the same series, OATS survival stayed above 80% for 7 years and above 60% at 15 years, while microfracture survival fell below 80% within 12 months and below 60% within 3 years.

A broader 2024 systematic review focusing on medium-to-large defects reported a recurring pattern with microfracture: acceptable short- to mid-term improvement for some patients, but deterioration in scores over time, with relatively high rates of failure, reoperation and radiographic osteoarthritis, particularly as defect size increases.

Elite-sport data help translate this into real-world durability. In a series of 50 elite athletes treated between 2011 and 2020, 94% returned to play at a mean of 9.3 months, but only 54.5% were still competing at 5 years; larger lesions (over 2 cm in diameter) and multiple lesions reduced both return and longer-term participation.

MACI sits at the other end of the spectrum: it is a cell-based membrane implant designed to produce a more hyaline-like repair. In the randomised SUMMIT trial (lesions ≥3 cm²), MACI produced better knee pain and function scores at 2 and 5 years than microfracture.

Cost analyses underline why the discussion often becomes a trade-off rather than a “best” operation: microfracture tends to be cheaper per unit of early functional gain, while grafting and cell-based techniques can offer larger improvements in suitable patients, with higher upfront cost.

Choice still depends on defect size and location, any previous surgery, limb alignment (sometimes needing osteotomy), and the goal — for example, “back to recreational running” versus “coping with a manual job for the next 10 years.”

Getting knee cartilage repair on the NHS in Lincolnshire

Most NHS knee cartilage journeys in Lincolnshire start with a GP appointment, because the first question is usually whether the problem can be managed safely with self‑care, pain relief and physiotherapy (the standard approach described on NHS knee pain guidance). For common “knee cartilage damage” problems such as a meniscus tear, NHS advice pages focus on symptoms, ways to ease pain and swelling at home, and clear thresholds for getting medical help rather than jumping straight to surgery.

If pain, swelling or mechanical symptoms persist despite a course of community MSK care, the next step is typically a referral into trauma and orthopaedics for assessment and (where needed) imaging and surgical opinion. When the discussion moves from symptom control to joint‑preservation surgery for a focal cartilage defect, what is available locally can vary: advanced cartilage restoration is not provided by every district general hospital, and some patients are referred on under NHS commissioning arrangements.

NICE technology appraisal TA477 sets out where autologous chondrocyte implantation (including MACI) fits. It recommends ACI/MACI as an option for adults with symptomatic full‑thickness defects in specific areas of the knee (such as the femoral condyle or patella), with minimal osteoarthritis, after previous conventional surgical treatment has failed—and it states that NHS commissioners and providers should ensure funding is available when those criteria are met. In practice, that usually means treatment is concentrated in commissioned specialist centres, with referral decisions made case‑by‑case.

Waiting times are best understood as moving targets, not promises. United Lincolnshire Hospitals NHS Trust (ULHT) publishes specialty waiting‑time information on My Planned Care, and the ULHT page explicitly notes that waits can vary with clinical condition (it was last updated on 22 May 2026). Northern Lincolnshire and Goole NHS Foundation Trust also publishes new outpatient and diagnostic waits in weeks, updated monthly, and describes these figures as forecasts that may change across sites such as Grimsby, Scunthorpe and Goole.

To keep this practical, the key points are summarised here rather than listing live web figures in‑line:

• These pages are useful for a general sense of scale (weeks, not days), but not for predicting an individual appointment date.
• If symptoms clearly deteriorate (for example, worsening swelling, repeated locking, or a new loss of function over 7–14 days), NHS guidance and local waiting‑time pages indicate that contacting the GP or hospital team is appropriate while waiting.
• When a cartilage‑restoration pathway is being considered, it is reasonable for the clinical conversation to include whether referral to a cartilage specialist centre is needed under TA477 commissioning criteria.

Private knee cartilage repair options with Lincolnshire Knee

Private care mainly changes the logistics around a knee cartilage problem: how quickly a specialist opinion and imaging can be arranged, and how much continuity there is between assessment, investigations and rehabilitation planning in places such as Sleaford (NG34) and Grantham (NG31). To keep this clinically grounded, the emphasis here is on what a private assessment can (and cannot) change in practice, rather than on promotional messaging.

Lincolnshire Knee (within the MSK Doctors group) describes a consultant-led, direct-access pathway with “minimal waiting” and the option that “one visit can include consultation, scan and treatment” at its Sleaford site (MSK House, London Road, Silk Willoughby, Sleaford NG34 8NY), including open MRI on site. In practice, a cartilage-focused consultation usually centres on a detailed history (including swelling patterns and mechanical symptoms), examination, and review of any existing MRI or arthroscopy findings before deciding whether further imaging is needed.

Where additional diagnostics are helpful, MSK Doctors presents its clinics as CQC-registered and offering “advanced diagnostics” and care “without referral and waiting list”. Depending on the clinical question, “advanced diagnostics” may include cartilage-sensitive MRI planning and (where available and appropriate) AI-assisted MRI workflows (for example, tools branded as onMRI™) or objective movement testing (for example, MAI Motion®) to quantify how the knee behaves during walking, stairs or sport—useful when joint-preservation decisions depend on mechanics as much as the cartilage defect itself.

Options discussed after a private cartilage assessment commonly sit on a spectrum, and do not automatically mean surgery:

• Optimised physiotherapy, activity and load management, and bracing (often a first step for many symptomatic knees).
• Image-guided injections as adjuncts for pain and inflammation control, where appropriate.
• Cartilage-preserving procedures for suitable focal defects (for example OATS/mosaicplasty, AMIC, and MACI/ACI in selected cases).
• Outpatient, ultrasound-guided injectable scaffold approaches (for example ChondroFiller™/Liquid Cartilage™) for selected focal defects, where offered.
• Alignment surgery such as osteotomy when malalignment is driving overload in one compartment.

Private input can also sit alongside ongoing NHS care: summaries can be shared with the GP, existing NHS imaging can be incorporated, and an opinion can clarify whether a cartilage-restoration referral is worth pursuing through commissioned pathways. Lincolnshire Knee is part of the MSK Doctors group and accepts patients without referral. Book an assessment at lincolnshireknee.co.uk. An assessment is a decision point, not a commitment to any procedure.

Deciding on timing and questions to ask your knee surgeon

A cartilage-preservation consultation works best when it ends with a clear shared picture of (1) the defect, (2) the realistic menu of options, and (3) the rehabilitation “bandwidth” available over the next 6–12 months—because NICE commissioning for ACI/MACI (TA477) is anchored to symptomatic full‑thickness defects with minimal osteoarthritis, which is effectively a “joint‑preservation window” for some knees rather than a guarantee at any time point.

Useful question stems (NHS or private) include:

• “What exactly is the cartilage problem?” Ask for the size (cm²), grade, and location (e.g., femoral condyle vs patella), because defect area is repeatedly used to stratify options in cartilage texts (with a practical split around 2–4 cm²).
• “Which procedures are genuinely on the table for this knee, and why?” A surgeon can then relate the choice to defect size and demands (microfracture, OATS/mosaicplasty, MACI/ACI), rather than naming a technique in isolation.
• “What does the rehab commitment look like for each option?” Cover concrete logistics: time on crutches, time off work, when driving may be realistic, and how return to sport is staged (MACI rehabilitation is commonly structured and prolonged, and varies by approach and combined procedures).
• “What is the long‑term outlook?” Ask how long benefits tend to last in published series, what proportion need further surgery, and how this might delay or avoid knee replacement (microfracture data in medium‑to‑large defects suggest outcomes can deteriorate at longer follow‑up, with higher reoperation/failure signals).

Where there has already been arthroscopy—especially microfracture or debridement—an important follow‑up is: “How does that previous procedure affect the next step (OATS, MACI/ACI, scaffold options), and do we need imaging that specifically assesses the bone under the defect?” This keeps the plan grounded in the condition of both cartilage and the supporting subchondral bone.

Timing decisions often come down to one practical output: leaving the appointment with a written summary that lists the defect measurements, the top 2–3 options, and the single next decision point (for example, “repeat MRI protocol”, “alignment assessment”, or “rehab plan and review date”), rather than an open‑ended wait‑and‑see trajectory.

1. [1] Autologous chondrocyte implantation, matrix‐induced autologous chondrocyte implantation, osteochondral autograft transplantation and osteochondral allograft improve knee function and pain with considerations for patient and cartilage defects characteristics: A systematic review and meta‐analysis. (2024). https://doi.org/10.1002/ksa.12525 https://doi.org/10.1002/ksa.12525